Informatie:
Fout:
ID
17150
Beschrijving
A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT00214214
Link
https://clinicaltrials.gov/show/NCT00214214
Trefwoorden
Versies (1)
- 28-08-16 28-08-16 -
Geüploaded op
28 augustus 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility New Onset Type 1 Diabetes Mellitus NCT00214214
Eligibility New Onset Type 1 Diabetes Mellitus NCT00214214
- StudyEvent: Eligibility
Similar models
Eligibility New Onset Type 1 Diabetes Mellitus NCT00214214
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Age, Diabetes Mellitus Type I
Item
adult subjects ages 18-35, with new onset type 1 diabetes mellitus (within 2-12 weeks of diagnosis), one or more islet autoantibody to gad, ia2, iaa or islet cell cytoplasmic antibody (ica) within 2 weeks of diabetes diagnosis.
boolean
C0001779 (UMLS CUI [1])
C0011854 (UMLS CUI [2])
C1167897 (UMLS CUI [3])
C3203592 (UMLS CUI [4])
C1275890 (UMLS CUI [5])
C0063900 (UMLS CUI [6])
C0011854 (UMLS CUI [2])
C1167897 (UMLS CUI [3])
C3203592 (UMLS CUI [4])
C1275890 (UMLS CUI [5])
C0063900 (UMLS CUI [6])
Age
Item
subjects under 18 years of age or over 35 years of age.
boolean
C0001779 (UMLS CUI [1])
Organ transplant
Item
subjects who have previously received an organ transplant.
boolean
C0029216 (UMLS CUI [1])
Systemic corticosteroids
Item
subjects who are currently receiving systemic corticosteroids for other medical diseases in which the physician feels discontinuation of corticosteroids is contraindicated.
boolean
C2825233 (UMLS CUI [1])
Other medical condition(s) known to affect blood glucose values
Item
subjects with a history of other medical condition(s) known to affect blood glucose values (i.e., cushing's disease, acromegaly).
boolean
C0012634 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0005802 (UMLS CUI [1,3])
C0392760 (UMLS CUI [1,2])
C0005802 (UMLS CUI [1,3])
Chronic systemic inflammatory or autoimmune disease or other severe medical condition
Item
subjects with a history of other chronic systemic inflammatory or autoimmune disease or other severe medical condition. (a history of treated hypothyroidism with documentation of normal serum thyroid hormone levels will not be exclusionary.)
boolean
C1290884 (UMLS CUI [1])
C0004364 (UMLS CUI [2])
C0009488 (UMLS CUI [3])
C0004364 (UMLS CUI [2])
C0009488 (UMLS CUI [3])
Hepatitis B, Hepatitis C, or HIV
Item
patients with a history of hepatitis b, hepatitis c, or hiv.
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
C0019693 (UMLS CUI [3])
C0019196 (UMLS CUI [2])
C0019693 (UMLS CUI [3])
PPD positive
Item
ppd positive at the time of evaluation.
boolean
C0032739 (UMLS CUI [1])
Thrombocytopenia or neutropenia
Item
thrombocytopenia or neutropenia. individuals will be considered to have thrombocytopenia if they have a platelet count <100,000 platelets/mm2 or <3,000 wbc/ml.
boolean
C0032181 (UMLS CUI [1])
C0023508 (UMLS CUI [2])
C0023508 (UMLS CUI [2])
Renal, pulmonary, or cardiac failure
Item
subjects with a history of renal, pulmonary, or cardiac failure
boolean
C0035078 (UMLS CUI [1])
C0948755 (UMLS CUI [2])
C0018801 (UMLS CUI [3])
C0948755 (UMLS CUI [2])
C0018801 (UMLS CUI [3])
Infection
Item
subjects with severe systemic infections. only those subjects who have completed treatment and have shown a complete clinical resolution will be considered eligible for the study.
boolean
C0009450 (UMLS CUI [1])